Q’Apel announces US FDA clearance of Zebra neurovascular access system, prepares for full US...
Q'Apel Medical has announced the receipt of US Food and Drug Administration (FDA) clearance for its Zebra neurovascular access system, with a full US...
PreSize Neurovascular clinical impact trial gains ESMINT endorsement
Oxford Heartbeat has shared that the clinical impact trial of its decision-support software, PreSize Neurovascular, has been endorsed by the European Society of Minimally...
UK researchers to elucidate endovascular brain aneurysm treatments via SEATED study
A major, UK-wide study—led by researchers from the School of Biomedical Engineering and Imaging Sciences at King’s College London (London, UK)—has been initiated to...
Methinks AI receives US FDA 510(k) clearance for NCCT Stroke software
Methinks AI announced today that its non-contrast computed tomography (NCCT) Stroke software has received 510(k) clearance from the US Food and Drug Administration (FDA)....
